BRUKER CORPORATION Segment Expenditure Addition To Long Lived Assets
BRUKER CORPORATION (BRKR) reported Segment Expenditure Addition To Long Lived Assets of $20.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentExpenditureAdditionToLongLivedAssets · last filed 2026-08-05
- BRUKER CORPORATION segment expenditure addition to long lived assets for the quarter ending 2026-06-30 was $20.30M, a 33.00% decline year-over-year.
- BRUKER CORPORATION segment expenditure addition to long lived assets for the quarter ending 2026-03-31 was $17.90M, a 31.15% decline year-over-year.
- BRUKER CORPORATION segment expenditure addition to long lived assets for the quarter ending 2025-12-31 was $28.10M, a 23.43% decline year-over-year.
- BRUKER CORPORATION segment expenditure addition to long lived assets for the quarter ending 2025-09-30 was $18.60M, a 42.94% decline year-over-year.
- BRUKER CORPORATION segment expenditure addition to long lived assets for fiscal 2025 was $103.00M, a 10.67% decline from fiscal 2024.
- BRUKER CORPORATION segment expenditure addition to long lived assets for fiscal 2024 was $115.30M, a 7.86% increase from fiscal 2023.
- BRUKER CORPORATION segment expenditure addition to long lived assets for fiscal 2023 was $106.90M, a 17.26% decline from fiscal 2022.
- BRUKER CORPORATION segment expenditure addition to long lived assets for fiscal 2022 was $129.20M, a 40.43% increase from fiscal 2021.
| Period end | Segment Expenditure Addition To Long Lived Assets 3 month | Segment Expenditure Addition To Long Lived Assets 6 month | Segment Expenditure Addition To Long Lived Assets 9 month | Segment Expenditure Addition To Long Lived Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $20.30M 10-Q · filed 2026-08-05 | $38.20M 10-Q · filed 2026-08-05 | $66.30M derived: sum of 3 quarters · filed 2026-08-05 | $84.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $17.90M 10-Q · filed 2026-05-07 | $46.00M derived: sum of 2 quarters · filed 2026-05-07 | $64.60M derived: sum of 3 quarters · filed 2026-05-07 | $94.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $28.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $46.70M derived: sum of 2 quarters · filed 2026-02-27 | $77.00M derived: sum of 3 quarters · filed 2026-08-05 | $103.00M 10-K · filed 2026-02-27 |
| 2025-09-30 | $18.60M 10-Q · filed 2025-11-05 | $48.90M derived: sum of 2 quarters · filed 2026-08-05 | $74.90M 10-Q · filed 2025-11-05 | $111.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $30.30M 10-Q · filed 2026-08-05 | $56.30M 10-Q · filed 2026-08-05 | $93.00M derived: sum of 3 quarters · filed 2026-08-05 | $125.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $26.00M 10-Q · filed 2026-05-07 | $62.70M derived: sum of 2 quarters · filed 2026-05-07 | $95.30M derived: sum of 3 quarters · filed 2026-05-07 | $119.80M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $36.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $69.30M derived: sum of 2 quarters · filed 2026-02-27 | $93.80M derived: sum of 3 quarters · filed 2026-02-27 | $115.30M 10-K · filed 2026-02-27 |
| 2024-09-30 | $32.60M 10-Q · filed 2025-11-05 | $57.10M derived: sum of 2 quarters · filed 2025-11-05 | $78.60M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $24.50M 10-Q · filed 2025-08-06 | $46.00M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $21.40M 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $106.90M 10-K · filed 2026-02-27 | |||
| 2022-12-31 | $129.20M 10-K · filed 2025-03-03 | |||
| 2021-12-31 | $92.00M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |